ALFATIL LP 500 mg, extended-release film-coated tablet 8 tablets
Active ingredients: Anhydrous cefaclor, Cefaclor
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release film-coated tablet8 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALFATIL LP 500 mg, comprimé pelliculé à libération prolongée
- Pharmaceutical form
- comprimé pelliculé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène aluminium-ACLAR de 8 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES ETHYPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1994
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66470506CIP73357599CIP133400933575991Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFACLOR MONOHYDRATÉcomprimé | 523 mg · un comprimé | SA |
| CÉFACLOR ANHYDREcomprimé | 500 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.